Currently browsing: Insights

Review of JPM 2026

JPM 2026 made one thing clear: AI in drug discovery is no longer “the story” — it’s the infrastructure   San Francisco’s J.P. Morgan Healthcare Conference has always been a [...] Read more

Workforce Planning for 2026

Workforce Planning for 2026: How Biotech and Pharma Can Build an AI-Ready R&D Organisation Executive Summary Workforce planning in 2026 looks fundamentally different from even three years ago. The rapid [...] Read more